In the evolving landscape of telehealth, many patients wonder if they can receive effective ADHD treatment without visiting a doctor’s office. Particularly for non-stimulant medications like Strattera (atomoxetine), the rules can be confusing. The good news is that in most cases, yes—you can get non-stimulant ADHD medication through telehealth services across the United States.
This comprehensive guide will walk you through the current telehealth regulations for non-stimulant ADHD medications, with state-specific information to help you understand your options.
Understanding Non-Stimulant ADHD Medications and Telehealth
Non-stimulant medications like Strattera work differently than stimulants (such as Adderall or Ritalin). The key difference from a regulatory perspective is that Strattera is not classified as a controlled substance by the DEA, making it subject to fewer restrictions when prescribed through telehealth.
Key Facts About Strattera (Atomoxetine):
Not a controlled substance – It doesn’t carry the same legal restrictions as stimulant medications
No abuse potential – Not habit-forming, which means it can be prescribed more flexibly
Can be prescribed with refills – Unlike stimulants, which typically require a new prescription each month
Takes 4-6 weeks for full effect – Unlike stimulants, which work immediately
Can be prescribed in 90-day supplies – For greater convenience once stable on the medication
Free consultations available with select providers only.
Free consultations available with select providers only.
Federal Telehealth Rules for Non-Stimulant ADHD Medications
At the federal level, there’s good news: non-stimulant ADHD medications like Strattera can be legally prescribed via telehealth with no federal requirement for an in-person visit.
While the Ryan Haight Act normally requires an initial in-person medical evaluation before prescribing controlled substances, this requirement does not apply to non-controlled medications like Strattera. This means that from a federal perspective, a licensed provider can evaluate you over video, confirm an ADHD diagnosis, and e-prescribe Strattera if appropriate.
State-by-State Telehealth Rules for Non-Stimulant ADHD Medications
While federal law permits telehealth prescribing of non-stimulant ADHD medications, state laws can add additional requirements. Here’s what you need to know about key states:
California
Telehealth for non-stimulants: Fully allowed
In-person exam required: None for non-stimulant medications
NP/PA prescribing authority: Independent practice for NPs after meeting experience requirements
Recent updates: California continues to support telehealth expansion, with ongoing proposals to further modernize telehealth definitions
New York
Telehealth for non-stimulants: Fully allowed
In-person exam required: None for non-stimulant medications (though NY reinstated in-person requirements for controlled substances in 2025)
NP/PA prescribing authority: NPs can practice independently after 3,600 hours
Recent updates: NY implemented stricter rules for controlled substances in 2025, but these don’t affect non-stimulants like Strattera
Florida
Telehealth for non-stimulants: Fully allowed
In-person exam required: None
NP/PA prescribing authority: Collaborative practice required (NP/PA must have a physician agreement)
Recent updates: Florida has permanently established telehealth medication rules, including for psychiatric conditions
Texas
Telehealth for non-stimulants: Fully allowed
In-person exam required: None for non-controlled medications
NP/PA prescribing authority: Collaborative practice required; NPs/PAs can prescribe non-controlled medications like Strattera
Recent updates: Texas remains telehealth-friendly, especially for mental health care
Alabama
Telehealth for non-stimulants: Allowed
In-person exam required: Annual visit (after 4 telehealth visits for the same condition) – however, mental health services are exempt from this rule
NP/PA prescribing authority: Collaborative practice required
Recent updates: Alabama maintains stricter telehealth rules than many states, but mental health treatment receives exemptions
New Hampshire
Telehealth for non-stimulants: Fully allowed
In-person exam required: None for non-controlled medications
NP/PA prescribing authority: Independent practice allowed for NPs
In-person exam required: None for non-controlled medications
NP/PA prescribing authority: Collaborative practice required
Recent updates: No major telehealth law changes in 2025; NPs remain restricted from prescribing Schedule II drugs
Who Can Prescribe Non-Stimulant ADHD Medications via Telehealth?
Physicians (MD/DO): Licensed physicians in all states can prescribe non-stimulant ADHD medications via telehealth
Nurse Practitioners (NPs): All states allow NPs to prescribe non-controlled medications like Strattera, either independently or with physician collaboration
Physician Assistants (PAs): Can prescribe non-stimulant medications in all states, though they typically require some form of physician supervision
What to Expect in a Telehealth ADHD Evaluation
A legitimate telehealth evaluation for ADHD should be comprehensive and thorough:
Complete history taking: The provider will ask detailed questions about your symptoms, when they began, and how they affect different areas of your life
DSM-5 criteria assessment: Using standardized criteria to confirm an ADHD diagnosis
Rating scales or questionnaires: You may be asked to complete assessments that measure symptom severity
Discussion of treatment options: Including both medication and non-medication approaches
Medication counseling: If Strattera is prescribed, your provider should discuss potential side effects, dosing, and what to expect
Follow-up planning: Regular follow-ups are essential, especially when starting a new medication
At Klarity Health, our providers conduct thorough ADHD evaluations that meet or exceed clinical standards. Our network includes licensed psychiatrists, psychiatric nurse practitioners, and other mental health specialists who have extensive experience in ADHD treatment. We accept both insurance and offer transparent cash pay options to make care accessible.
Common Misconceptions About Telehealth ADHD Treatment
Misconception: ‘Online ADHD prescriptions are automatic’
Reality: A legitimate telehealth consultation for ADHD should be comprehensive. Providers must follow the same diagnostic criteria and safe prescribing practices as in-person care. If a service seems too ‘easy’ (no detailed questions, guarantees medications), that’s a red flag.
Misconception: ‘Non-stimulants aren’t effective’
Reality: While stimulants are often first-line treatments, non-stimulants like Strattera can be very effective for many patients, especially those who can’t take stimulants due to side effects or other concerns. They work differently and may take longer to show full benefits, but can provide 24-hour symptom control.
Misconception: ‘If I get a prescription online, local pharmacies won’t fill it’
Reality: Most pharmacies will fill telehealth prescriptions from licensed practitioners. Electronic prescriptions are the norm and don’t indicate whether your visit was telehealth or in-person. Non-stimulant prescriptions like Strattera typically face no special scrutiny since they’re not controlled medications.
Tips for Successful Telehealth ADHD Treatment
Choose reputable platforms: Look for services that use licensed clinicians, require video visits, and have clear policies.
Be honest and thorough in your evaluation: The quality of your care depends on the information you provide.
Follow up regularly: Telehealth doesn’t end with the prescription. Regular follow-ups help ensure the medication is working properly.
Know your state’s rules: While the provider should handle compliance, it’s useful to be aware of your state’s specific requirements.
Take medication as prescribed: Even though Strattera isn’t a controlled substance, always use it exactly as directed.
Communicate side effects promptly: Let your provider know if you experience any side effects so they can help address them.
Stay updated on regulation changes: Telehealth rules continue to evolve, so maintain contact with your provider about any potential changes.